Michael Lilly

Also affiliated with MUSC Hollings Cancer Center

Physics and AstronomyEngineeringMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Moving on up: Second-Line Agents as Initial Treatment for Newly-Diagnosed Patients with Chronic Phase CML”.

Moving on up: Second-Line Agents as Initial Treatment for Newly-Diagnosed Patients with Chronic Phase CML

Clinical Medicine Insights: Oncology(2011)10.4137/cmo.s6416

N/A

0.312DataRank · unranked

7 citations

Masato Mitsuhashi, Michael Lilly, Marie P. Shieh

Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis

Cell Reports(2022)10.1016/j.celrep.2022.111742

N/A

0DataRank · unranked

29 citations

Mohamed Faisal Kassir, Firdevs Cansu Atilgan, Han Gyul Lee, Megan A. Sheridan, Natalia V. Oleinik +14 more